 | • レポートコード：QYR9ST04092 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、副腎皮質癌治療の世界市場について調査・分析し、副腎皮質癌治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（限局性副腎皮質癌、転移性副腎皮質癌）、用途別（病院、外来手術センター、診療所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の副腎皮質癌治療市場動向 ・主要企業別マーケットシェア ・副腎皮質癌治療の種類別市場規模2014-2019 （限局性副腎皮質癌、転移性副腎皮質癌） ・副腎皮質癌治療の用途別市場規模2014-2019 （病院、外来手術センター、診療所） ・副腎皮質癌治療の北米市場：主要企業・種類別/用途別市場規模 ・副腎皮質癌治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・副腎皮質癌治療の中国市場：主要企業・種類別/用途別市場規模 ・副腎皮質癌治療の日本国内市場：主要企業・種類別/用途別市場規模 ・副腎皮質癌治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・副腎皮質癌治療のインド市場：主要企業・種類別/用途別市場規模 ・副腎皮質癌治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （ArQule、EnGeneIC、Exelixis、Merck、Millendo Therapeutics、Orphagen Pharmaceuticals） ・副腎皮質癌治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Adrenocortical carcinoma (ACC) is a rare disease caused by cancerous growth in the adrenal cortex, which is the outer layer of the adrenal glands. The adrenal glands lie on top of the kidneys. They play a major role in the endocrine system, which is the system that produces and regulates hormones. The causes of primary adrenocortical carcinoma are unknown. However adrenocortical carcinoma can also be secondary cancer. A secondary cancer is what happens when another form of cancer spreads to the adrenal glands. Adrenocortical carcinoma can occur at any age, but there is a bimodal distribution with a first peak at childhood between 1–6 years old and the second peak in the fourth to the fifth decade of life. During the past decade, collaborative efforts have been made to improve the ACC treatment. Some of the key factors that are driving the adrenocortical carcinoma treatment market are increasing the prevalence of cancer, rising government involvement, increasing funding from various government and non-government organizations. Also, ethical acceptance of adrenocortical carcinoma treatment and high unmet needs in some regions are driving the adrenocortical carcinoma treatment market. However, less awareness and high cost involved in treatment are restraining the global adrenocortical carcinoma treatment market. Also, the introduction of generic drugs in some countries is restraining the growth of adrenocortical carcinoma treatment market. Also, despite the high cost involved in R&D, pharmaceutical companies are showing increased interest in this field. This is expected to offer good potential for adrenocortical carcinoma treatment market.
In 2018, the global Adrenocortical Carcinoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Adrenocortical Carcinoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Adrenocortical Carcinoma Treatment development in United States, Europe and China.
The key players covered in this study
ArQule
EnGeneIC
Exelixis
Merck
Millendo Therapeutics
Orphagen Pharmaceuticals
…
Market segment by Type, the product can be split into
Localized Adrenocortical Carcinoma
Metastatic Adrenocortical Carcinoma
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Clinics
Cancer Research Institutes
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Adrenocortical Carcinoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Adrenocortical Carcinoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Adrenocortical Carcinoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Localized Adrenocortical Carcinoma
1.4.3 Metastatic Adrenocortical Carcinoma
1.5 Market by Application
1.5.1 Global Adrenocortical Carcinoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Clinics
1.5.5 Cancer Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Adrenocortical Carcinoma Treatment Market Size
2.2 Adrenocortical Carcinoma Treatment Growth Trends by Regions
2.2.1 Adrenocortical Carcinoma Treatment Market Size by Regions (2014-2025)
2.2.2 Adrenocortical Carcinoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Adrenocortical Carcinoma Treatment Market Size by Manufacturers
3.1.1 Global Adrenocortical Carcinoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Adrenocortical Carcinoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Adrenocortical Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Adrenocortical Carcinoma Treatment Key Players Head office and Area Served
3.3 Key Players Adrenocortical Carcinoma Treatment Product/Solution/Service
3.4 Date of Enter into Adrenocortical Carcinoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019)
4.2 Global Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Adrenocortical Carcinoma Treatment Market Size (2014-2019)
5.2 Adrenocortical Carcinoma Treatment Key Players in United States
5.3 United States Adrenocortical Carcinoma Treatment Market Size by Type
5.4 United States Adrenocortical Carcinoma Treatment Market Size by Application
6 Europe
6.1 Europe Adrenocortical Carcinoma Treatment Market Size (2014-2019)
6.2 Adrenocortical Carcinoma Treatment Key Players in Europe
6.3 Europe Adrenocortical Carcinoma Treatment Market Size by Type
6.4 Europe Adrenocortical Carcinoma Treatment Market Size by Application
7 China
7.1 China Adrenocortical Carcinoma Treatment Market Size (2014-2019)
7.2 Adrenocortical Carcinoma Treatment Key Players in China
7.3 China Adrenocortical Carcinoma Treatment Market Size by Type
7.4 China Adrenocortical Carcinoma Treatment Market Size by Application
8 Japan
8.1 Japan Adrenocortical Carcinoma Treatment Market Size (2014-2019)
8.2 Adrenocortical Carcinoma Treatment Key Players in Japan
8.3 Japan Adrenocortical Carcinoma Treatment Market Size by Type
8.4 Japan Adrenocortical Carcinoma Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Adrenocortical Carcinoma Treatment Market Size (2014-2019)
9.2 Adrenocortical Carcinoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type
9.4 Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application
10 India
10.1 India Adrenocortical Carcinoma Treatment Market Size (2014-2019)
10.2 Adrenocortical Carcinoma Treatment Key Players in India
10.3 India Adrenocortical Carcinoma Treatment Market Size by Type
10.4 India Adrenocortical Carcinoma Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Adrenocortical Carcinoma Treatment Market Size (2014-2019)
11.2 Adrenocortical Carcinoma Treatment Key Players in Central & South America
11.3 Central & South America Adrenocortical Carcinoma Treatment Market Size by Type
11.4 Central & South America Adrenocortical Carcinoma Treatment Market Size by Application
12 International Players Profiles
12.1 ArQule
12.1.1 ArQule Company Details
12.1.2 Company Description and Business Overview
12.1.3 Adrenocortical Carcinoma Treatment Introduction
12.1.4 ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)
12.1.5 ArQule Recent Development
12.2 EnGeneIC
12.2.1 EnGeneIC Company Details
12.2.2 Company Description and Business Overview
12.2.3 Adrenocortical Carcinoma Treatment Introduction
12.2.4 EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)
12.2.5 EnGeneIC Recent Development
12.3 Exelixis
12.3.1 Exelixis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Adrenocortical Carcinoma Treatment Introduction
12.3.4 Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)
12.3.5 Exelixis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Adrenocortical Carcinoma Treatment Introduction
12.4.4 Merck Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Millendo Therapeutics
12.5.1 Millendo Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Adrenocortical Carcinoma Treatment Introduction
12.5.4 Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)
12.5.5 Millendo Therapeutics Recent Development
12.6 Orphagen Pharmaceuticals
12.6.1 Orphagen Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Adrenocortical Carcinoma Treatment Introduction
12.6.4 Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)
12.6.5 Orphagen Pharmaceuticals Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Adrenocortical Carcinoma Treatment Key Market Segments
Table Key Players Adrenocortical Carcinoma Treatment Covered
Table Global Adrenocortical Carcinoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Adrenocortical Carcinoma Treatment Market Size Market Share by Type 2014-2025
Figure Localized Adrenocortical Carcinoma Figures
Table Key Players of Localized Adrenocortical Carcinoma
Figure Metastatic Adrenocortical Carcinoma Figures
Table Key Players of Metastatic Adrenocortical Carcinoma
Table Global Adrenocortical Carcinoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Ambulatory Surgical Centers Case Studies
Figure Clinics Case Studies
Figure Cancer Research Institutes Case Studies
Figure Adrenocortical Carcinoma Treatment Report Years Considered
Table Global Adrenocortical Carcinoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Adrenocortical Carcinoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Adrenocortical Carcinoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Adrenocortical Carcinoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Adrenocortical Carcinoma Treatment Market Share by Regions 2014-2019
Figure Global Adrenocortical Carcinoma Treatment Market Share by Regions 2014-2019
Figure Global Adrenocortical Carcinoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Adrenocortical Carcinoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Adrenocortical Carcinoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Adrenocortical Carcinoma Treatment Market Share by Manufacturers in 2018
Table Global Adrenocortical Carcinoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Adrenocortical Carcinoma Treatment Product/Solution/Service
Table Date of Enter into Adrenocortical Carcinoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Adrenocortical Carcinoma Treatment Market Size Share by Type (2014-2019)
Figure Global Adrenocortical Carcinoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Adrenocortical Carcinoma Treatment Market Size Share by Application (2014-2019)
Figure Global Adrenocortical Carcinoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Adrenocortical Carcinoma Treatment Revenue Market Share by Application in 2018
Figure United States Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table United States Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table United States Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Figure Europe Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table Europe Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table Europe Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Figure China Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table China Adrenocortical Carcinoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table China Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Figure Japan Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table Japan Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table Japan Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Figure India Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table India Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table India Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Adrenocortical Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Adrenocortical Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Adrenocortical Carcinoma Treatment Market Share (2018-2019)
Table Central & South America Adrenocortical Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Adrenocortical Carcinoma Treatment Market Share by Type (2014-2019)
Table Central & South America Adrenocortical Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Adrenocortical Carcinoma Treatment Market Share by Application (2014-2019)
Table ArQule Company Details
Table ArQule Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019) (Million US$)
Figure ArQule Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2014-2019)
Table ArQule Recent Development
Table EnGeneIC Company Details
Table EnGeneIC Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)(Million US$)
Figure EnGeneIC Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2014-2019)
Table EnGeneIC Recent Development
Table Exelixis Company Details
Table Exelixis Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Exelixis Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2014-2019)
Table Exelixis Recent Development
Table Merck Company Details
Table Merck Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2014-2019)
Table Merck Recent Development
Table Millendo Therapeutics Company Details
Table Millendo Therapeutics Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Millendo Therapeutics Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2014-2019)
Table Millendo Therapeutics Recent Development
Table Orphagen Pharmaceuticals Company Details
Table Orphagen Pharmaceuticals Revenue in Adrenocortical Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Orphagen Pharmaceuticals Revenue Growth Rate in Adrenocortical Carcinoma Treatment Business (2014-2019)
Table Orphagen Pharmaceuticals Recent Development
Table Global Adrenocortical Carcinoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Adrenocortical Carcinoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Adrenocortical Carcinoma Treatment Market Size Share by Regions in 2025
Figure United States Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Adrenocortical Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Adrenocortical Carcinoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Adrenocortical Carcinoma Treatment Market Size by Product (2019-2025)
Figure Global Adrenocortical Carcinoma Treatment Market Size by Product in 2025
Table Global Adrenocortical Carcinoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Adrenocortical Carcinoma Treatment Market Size by Application (2019-2025)
Figure Global Adrenocortical Carcinoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
基底細胞癌治療の世界市場：市場規模・現状・予測 Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening…- 進行腎細胞癌治療薬の世界市場：市場規模・現状・予測 Advanced renal cell carcinoma is associated with a type of kidney cancer that appears in the covering of the proximal complex tubule. The convoluted tubule is a very small part of tubes in the kidney that helps in transportation of unwanted particles from the blood to the urine. Advanced renal cell …
- 神経内分泌癌の世界市場：インサイト・予測 Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …
- 肝細胞癌薬の世界市場：インサイト・予測 Hepatocellular Carcinoma Drug is a drug for treating Hepatocellular Carcinoma.The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a f…
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…